Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
European Journal of Cancer & Clinical Oncology
|
April 1, 1983
Effect of mannitol and plasma on the cytotoxicity of cisplatin
E E Holdener, C H Park, R J Belt, et al.
Schweizerische Medizinische Wochenschrift
|
October 18, 1975
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors]
W F Jungi, H J Senn, C Beckmann, et al.
Clinical Transplants
|
June 1, 2017
Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD)
Amanda J Condon, Brad C Astor, Kimberly E Holdener, et al.
British Journal of Urology
|
September 1, 1995
Interferon-alpha and survival in renal cell cancer
S Fossa, M Jones, P Johnson, et al.
Schweizerische Medizinische Wochenschrift
|
March 9, 1991
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
R Morant, B Thürlimann, W F Jungi, et al.
Investigational New Drugs
|
September 1, 1988
Phase II trial of menogaril in advanced colorectal cancer
E E Holdener, W W ten Bokkel Huinink, G Decoster, et al.
Onkologie
|
April 1, 1990
Improved tolerance of interferon alpha-2a by continuous subcutaneous infusion
C U Ludwig, R Ludwig-Hagemann, R Obrist, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
January 10, 1989
[Rare variants and unusual course of Cushing's syndrome]
W Tenschert, N Rolf, W Vetter, et al.
Schweizerische Medizinische Wochenschrift
|
December 3, 1983
[Deleterious course in tumor patients with ectopic ACTH secretion and secondary Cushing's syndrome]
E E Holdener, W G Tenschert, P U Heitz, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1984
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group
V H Bramwell, E E Holdener, P Siegenthaler, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
European Journal of Cancer & Clinical Oncology
|
April 1, 1983
Effect of mannitol and plasma on the cytotoxicity of cisplatin
E E Holdener, C H Park, R J Belt, et al.
Schweizerische Medizinische Wochenschrift
|
October 18, 1975
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors]
W F Jungi, H J Senn, C Beckmann, et al.
Clinical Transplants
|
June 1, 2017
Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD)
Amanda J Condon, Brad C Astor, Kimberly E Holdener, et al.
British Journal of Urology
|
September 1, 1995
Interferon-alpha and survival in renal cell cancer
S Fossa, M Jones, P Johnson, et al.
Schweizerische Medizinische Wochenschrift
|
March 9, 1991
[Peripheral spontaneous remission of hairy cell leukemia following transfusion-associated hepatitis C]
R Morant, B Thürlimann, W F Jungi, et al.
Investigational New Drugs
|
September 1, 1988
Phase II trial of menogaril in advanced colorectal cancer
E E Holdener, W W ten Bokkel Huinink, G Decoster, et al.
Onkologie
|
April 1, 1990
Improved tolerance of interferon alpha-2a by continuous subcutaneous infusion
C U Ludwig, R Ludwig-Hagemann, R Obrist, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|
January 10, 1989
[Rare variants and unusual course of Cushing's syndrome]
W Tenschert, N Rolf, W Vetter, et al.
Schweizerische Medizinische Wochenschrift
|
December 3, 1983
[Deleterious course in tumor patients with ectopic ACTH secretion and secondary Cushing's syndrome]
E E Holdener, W G Tenschert, P U Heitz, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1984
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group
V H Bramwell, E E Holdener, P Siegenthaler, et al.
Page
of 4